Cargando…

Analytical performance of the FDA-cleared Parsortix(®) PC1 system

INTRODUCTION: The Parsortix(®) PC1 system, Food and Drug Administration (FDA) cleared for use in metastatic breast cancer (MBC) patients, is an epitope-independent microfluidic device for the capture and harvest of circulating tumor cells from whole blood based on cell size and deformability. This r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Templeman, Amy, Miller, M. Craig, Cooke, Martin J., O’Shannessy, Daniel J., Gurung, Yuwaraj, Pereira, Tiago, Peters, Samuel G., Piano, Mario De, Teo, Manilyn, Khazan, Negar, Kim, Kyukwang, Cohen, Evan, Lopez, Heather B, Alvarez, Franklin, Ciccioli, Mariacristina, Pailhes-Jimenez, Anne-Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AboutScience 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434983/ https://www.ncbi.nlm.nih.gov/pubmed/37601320 http://dx.doi.org/10.33393/jcb.2023.2629

Ejemplares similares

The Parsortix™ Cell Separation System—A versatile liquid biopsy platform
por: Miller, M. Craig, et al.
Publicado: (2018)

A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix(®) PC1 System
por: Cohen, Evan N., et al.
Publicado: (2022)

Folate Receptor Alpha, Mesothelin and Megakaryocyte Potentiating Factor as Potential Serum Markers of Chronic Kidney Disease
por: Somers, Elizabeth B, et al.
Publicado: (2014)

Feasibility of an Intensive, Disorder-Specific, Group-Based Cognitive Behavioural Therapy Intervention for Adolescents with Social Anxiety Disorder
por: O’Shannessy, Dustin M., et al.
Publicado: (2021)

Towards an FDA-cleared basophil activation test
por: Alpan, Oral, et al.
Publicado: (2023)

Co-Development of Diagnostic Vectors to Support Targeted Therapies and Theranostics: Essential Tools in Personalized Cancer Therapy
por: Nicolaides, Nicholas C., et al.
Publicado: (2014)

Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream(®) for Detecting (or Monitoring) the Expression of Folate Receptor Alpha
por: O’Shannessy, Daniel J., et al.
Publicado: (2016)

Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease
por: O’Shannessy, Daniel J, et al.
Publicado: (2012)

Expression of folate receptors alpha and beta in normal and cancerous gynecologic tissues: correlation of expression of the beta isoform with macrophage markers
por: O’Shannessy, Daniel J, et al.
Publicado: (2015)

Endosialin and Associated Protein Expression in Soft Tissue Sarcomas: A Potential Target for Anti-Endosialin Therapeutic Strategies
por: O'Shannessy, Daniel J., et al.
Publicado: (2016)

Patient Satisfaction, Recommendation Rate, and Patient Comfort With an FDA-Cleared Cryolipolysis System
por: Altmann, Jens, et al.
Publicado: (2022)

Influence of tumor microenvironment on prognosis in colorectal cancer: Tissue architecture-dependent signature of endosialin (TEM-1) and associated proteins
por: O'Shannessy, Daniel J., et al.
Publicado: (2014)

Development of (89)Zr-Ontuxizumab for in vivo TEM-1/endosialin PET applications
por: Lange, Sara E.S., et al.
Publicado: (2016)

Novel Small Molecule MEK Inhibitor URML-3881 Enhances Cisplatin Sensitivity in Clear Cell Ovarian Cancer
por: Rowswell-Turner, Rachael B., et al.
Publicado: (2019)

Serum folate receptor alpha, mesothelin and megakaryocyte potentiating factor in ovarian cancer: association to disease stage and grade and comparison to CA125 and HE4
por: O’Shannessy, Daniel J, et al.
Publicado: (2013)

Activity, Participation, and Goal Awareness After Acquired Brain Injury: A Prospective Observational Study of Inpatient Rehabilitation
por: Adey-Wakeling, Zoe, et al.
Publicado: (2021)

Fluorescence polarization with FDA in leukaemic cells: a clear difference between myelogenous and lymphocytic origins.
por: Tsuda, H., et al.
Publicado: (1981)

Folate Receptor Alpha Expression in Lung Cancer: Diagnostic and Prognostic Significance
por: O'Shannessy, Daniel J., et al.
Publicado: (2012)

Gene Expression Analyses Support Fallopian Tube Epithelium as the Cell of Origin of Epithelial Ovarian Cancer
por: O’Shannessy, Daniel J., et al.
Publicado: (2013)

Non-invasive digestion monitoring with an FDA-cleared wearable biosensor: further validation for use in tracking food ingestion
por: Cohen, Erica R, et al.
Publicado: (2021)

Endosialin Expression in Metastatic Melanoma Tumor Microenvironment Vasculature: Potential Therapeutic Implications
por: Kiyohara, Eiji, et al.
Publicado: (2015)

In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors
por: Gurung, Arun Bahadur
Publicado: (2020)

Significant Improvement in Detecting BRAF, KRAS, and EGFR Mutations Using Next-Generation Sequencing as Compared with FDA-Cleared Kits
por: Ma, Wanlong, et al.
Publicado: (2017)

639. Performance Characteristics of an FDA Cleared Multiplex Panel for the Rapid Identification of Fungal Pathogens From Positive Blood Culture
por: Zhang, Sean, et al.
Publicado: (2019)

Rationale for Use of an FDA-Cleared Delivery System for Administration of Inhaled Nitric Oxide in Patients Undergoing Magnetic Resonance Imaging
por: Salas, Mauro, et al.
Publicado: (2021)

Stratified assessment of an FDA-cleared deep learning algorithm for automated detection and contouring of metastatic brain tumors in stereotactic radiosurgery
por: Wang, Jen-Yeu, et al.
Publicado: (2023)

The power of public–private partnership in medical technology innovation: Lessons from the development of FDA-cleared medical devices for assessment of concussion
por: Singer, Michael E., et al.
Publicado: (2022)

The FDA Changed Everything
por: Geantă, Marius, et al.
Publicado: (2017)

Rediscovering FDA Websites
por: Navarro, Robert P.
Publicado: (2012)

In silico screening of FDA approved drugs reveals ergotamine and dihydroergotamine as potential coronavirus main protease enzyme inhibitors
por: Gurung, Arun Bahadur, et al.
Publicado: (2020)

The apparent action causation: Using a magician forcing technique to investigate our illusory sense of agency over the outcome of our choices
por: Pailhès, Alice, et al.
Publicado: (2020)

Subtly encouraging more deliberate decisions: using a forcing technique and population stereotype to investigate free will
por: Pailhès, Alice, et al.
Publicado: (2020)

FDA oversight of medical devices
por: Hill, Matthew W, et al.
Publicado: (2012)

FDA eyes pharmacogenomics data.
por: Wakefield, Julie
Publicado: (2004)

The FDA initiatives for personalized medicine
por: Wolfe, Olive Joy
Publicado: (2014)

2017 FDA Peptide Harvest
por: Al Musaimi, Othman, et al.
Publicado: (2018)

2018 FDA Tides Harvest
por: Al Shaer, Danah, et al.
Publicado: (2019)

FDA Approvals of Biologics in 2022
por: Martins, Alexander C., et al.
Publicado: (2023)

Accurate Identification of ALK Positive Lung Carcinoma Patients: Novel FDA-Cleared Automated Fluorescence In Situ Hybridization Scanning System and Ultrasensitive Immunohistochemistry
por: Conde, Esther, et al.
Publicado: (2014)

Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
por: Van Norman, Gail A.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pb5pi1ceeskobevgrb4ad2bfif